cCMV Research Study
Congenital cytomegalovirus (cCMV) is an infection passed to infants in the womb and occurs in about 1 in 200 infants. Some newborns show immediate signs of this infection, but others show minimal to no signs of infection. Current knowledge about how cCMV infections impact brain development is limited, especially for children that have no major signs or symptoms at birth.
Our research team is hoping to change that. This study aims to better understand the full impact of cCMV infection on brain and early childhood development in children who showed few to no symptoms at birth. Learn more about this study on the CMV research website.
If your newborn tested positive for CMV, you may be eligible to participate!
Study Contact
- Maya Dosembet, Study Coordinator
- 612-626-8233
- cmvresearch@umn.edu
Who Can Participate in the Study
Families who have an infant 12-months of age or younger AND was identified as CMV positive at birth via the Minnesota Newborn Screening program. This screening is performed from a dried blood spot test (usually done as a heel prick).
We have some additional criteria that our staff will ask you about when you contact us.
What's involved in Participating in the Study?
Participants come to Minneapolis for study visits when children are 12-months, 24-months and 36-months of age. Each visit involves developmental testing. When children are 12-months the study visit also includes at least one brain MRI scan when the child is natural sleeping (no sedation or radiation). We schedule visits at your convenience and at no cost to you.
Families receive reports on their child’s developmental testing, up to $500 compensation, as well as reimbursement for travel expenses to Minneapolis.
Interested in Learning More?
Contact us or complete the study interest form to learn more!